Search Results - "Kollars, Marietta"

Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation by Hron, Gregor, Kollars, Marietta, Binder, Bernd R, Eichinger, Sabine, Kyrle, Paul A

“…CONTEXT Screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors is common clinical practice. Because of the large number of risk…”
Get full text

Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer by Hron, Gregor, Kollars, Marietta, Weber, Heinz, Sagaster, Verena, Quehenberger, Peter, Eichinger, Sabine, Kyrle, Paul A, Weltermann, Ansgar

“…The pathogenesis of hypercoagulability in cancer is not entirely understood. We hypothesized that in cancer patients circulating tissue factor-positive…”
Get more information

Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer by Eichinger, Sabine, Hron, Gregor, Kollars, Marietta, Kyrle, Paul A

“…Increased thrombin generation is associated with an increased risk of recurrent venous thromboembolism. We investigated the relation between endogenous…”
Get full text

Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects by Krammer, Teresa L, Kollars, Marietta, Kyrle, Paul A, Hackl, Matthias, Eichinger, Sabine, Traby, Ludwig

“…Platelets are the main effectors of primary hemostasis but also cause thrombosis in pathological conditions. Antiplatelet drugs are the cornerstone for the…”
Get full text

Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study by Traby, Ludwig, Kollars, Marietta, Eischer, Lisbeth, Eichinger, Sabine, Kyrle, Paul A

“…Venous thromboembolism (VTE) is a chronic disease, which tends to recur. Whether an abnormal fibrinolytic system is associated with an increased risk of VTE is…”
Get full text

Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism by Hoke, Matthias, Kyrle, Paul A, Minar, Erich, Bialonzcyk, Christine, Hirschl, Mirko, Schneider, Barbara, Kollars, Marietta, Weltermann, Ansgar, Eichinger, Sabine

“…Tissue factor pathway inhibitor (TFPI) regulates factor X activation. Low TFPI is a risk factor for a first venous thrombosis. We evaluated whether low TFPI…”
Get more information

Prediction of recurrent venous thromboembolism by measuring ProC Global by Eichinger, Sabine, Hron, Gregor, Hirschl, Mirko, Bialonczyk, Christine, Minar, Erich, Kollars, Marietta, Kyrle, Paul A

“…In patients with venous thromboembolism (VTE) a laboratory assay that globally measures the overall thrombophilic tendency is not available. We hypothesized…”
Get more information

Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients by Traby, Ludwig, Kollars, Marietta, Kussmann, Manuel, Karer, Matthias, Šinkovec, Hana, Lobmeyr, Elisabeth, Hermann, Alexander, Staudinger, Thomas, Schellongowski, Peter, Rössler, Bernhard, Burgmann, Heinz, Kyrle, Paul A, Eichinger, Sabine

“…Pulmonary thrombus formation is a hallmark of coronavirus disease 2019 (COVID-19). A dysregulated immune response culminating in thromboinflammation has been…”
Get more information

Differential Effects of Clopidogrel With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers by Traby, Ludwig, Kollars, Marietta, Kaider, Alexandra, Siller‐Matula, Jolanta Maria, Steinbrecher, Oskar, Wolzt, Michael, Kyrle, Paul Alexander, Eichinger, Sabine

“…Dual antiplatelet therapy (DAPT) is standard in acute coronary syndrome but confers a bleeding risk. To compare effects of clopidogrel single antiplatelet…”
Get full text

MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary Report by Gabler, Jessica, Basílio, José, Steinbrecher, Oskar, Kollars, Marietta, Kyrle, Paul A., Eichinger, Sabine

“…Venous thromboembolism (VTE) is a frequent and potentially fatal disease, but its pathophysiology is incompletely understood. microRNAs (miR) dysregulate…”
Get full text

Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers by Traby, Ludwig, Kollars, Marietta, Kaider, Alexandra, Siller‐Matula, Jolanta M., Wolkersdorfer, Martin F., Wolzt, Michael, Kyrle, Paul A., Eichinger, Sabine

“…Dual antiplatelet therapy (DAPT) is standard in acute coronary heart disease but confers a bleeding risk. To compare the effects of ticagrelor‐monotherapy with…”
Get full text

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Colorectal Cancer Patients: A Pilot Study by Traby, Ludwig, Puhr, Hannah C., Kollars, Marietta, Michael, Kammer, Prager, Gerald, Scheithauer, Werner, Kornek, Gabriela, Kyrle, Paul Alexander, Eichinger, Sabine

“…Introduction Venous thromboembolism is a frequent complication in cancer patients and results in a considerable morbidity and mortality. The underlying…”
Get full text

Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans by Lubsczyk, Barbara, Kollars, Marietta, Hron, Gregor, Kyrle, Paul A, Weltermann, Ansgar, Gartner, Verena

“…Eur J Clin Invest 2010; 40 (6): 477–482 Background  Microparticles (MPs) have procoagulant properties as shown in vitro and in animal models. Their role in…”
Get full text

Tissue factor exposing microparticles in inflammatory bowel disease by Palkovits, Julia, Novacek, Gottfried, Kollars, Marietta, Hron, Gregor, Osterode, Wolf, Quehenberger, Peter, Kyrle, Paul Alexander, Vogelsang, Harald, Reinisch, Walter, Papay, Pavol, Weltermann, Ansgar

“…Circulating procoagulant microparticles (MPs) are thought to be involved in the pathogenesis of venous thromboembolism in patients with inflammatory bowel…”
Get full text

Hypofibrinolysis and the Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study by Eichinger, Sabine, Traby, Ludwig, Heinze, Georg, Kollars, Marietta, Eischer, Lisbeth, Kyrle, Paul Alexander

“…Abstract 3331 Hypercoagulability reflected by enhanced activity of clotting factors or a natural inhibitor deficiency is a risk factor of venous…”
Get full text

Characterization of the Procoagulant Activity of Two Different Microparticle Species by Traby, Ludwig, Kollars, Marietta, Shoumariyeh, Khalid, Weltermann, Ansgar, Kyrle, Paul Alexander, Eichinger, Sabine, Lechner, Daniel

“…Abstract 1143 Microparticles (MP) exhibit procoagulant activity by exposure of tissue factor (TF) and consecutive factor (F) × activation via binding to…”
Get full text

Pathophysiology of Trousseau's syndrome by Dicke, C, Langer, F

“…Clinically relevant clotting abnormalities in cancer patients are referred to as Trousseau's syndrome. While thrombotic complications such as venous…”
Get more information

1,25-Dihydroxyvitamin D 3 inhibits dendritic cell differentiation and maturation in vitro by Berer, Andrea, Stöckl, Johannes, Majdic, Otto, Wagner, Thomas, Kollars, Marietta, Lechner, Klaus, Geissler, Klaus, Oehler, Leopold

“…Because of its potent immunosuppressive properties in vitro as well as in vivo, we studied the effect of 1,25-dihydroxyvitamin D 3 (calcitriol) on…”
Get full text

1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro by Berer, Andrea, Stöckl, Johannes, Majdic, Otto, Wagner, Thomas, Kollars, Marietta, Lechner, Klaus, Geissler, Klaus, Oehler, Leopold

Get full text

ProCGlobal and endogenous thrombin potential during pregnancy by Hron, Gregor, MD, Kyrle, Paul A., MD, Kaider, Alexandra, MSc, Philipp, Karl, MD, Pabinger, Ingrid, MD, Kollars, Marietta, Eichinger, Sabine, MD

“…Objective Pregnancy is a hypercoagulable state. We evaluated global markers of coagulation activation, ProCGlobal (Siemens Healthcare Diagnostics, Eschborn,…”
Get full text